Citation: Ld. Carlton et al., THE EFFECTS OF EPOPROSTENOL ON DRUG DISPOSITION .1. A PILOT-STUDY OF THE PHARMACOKINETICS OF DIGOXIN WITH AND WITHOUT EPOPROSTENOL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Journal of clinical pharmacology, 36(3), 1996, pp. 247-256
Citation: Ld. Carlton et al., THE EFFECTS OF EPOPROSTENOL ON DRUG DISPOSITION .2. A PILOT-STUDY OF THE PHARMACOKINETICS OF FUROSEMIDE WITH AND WITHOUT EPOPROSTENOL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Journal of clinical pharmacology, 36(3), 1996, pp. 257-264
Authors:
LIEN CA
SCHMITH VD
BELMONT MR
ABALOS A
KISOR DF
SAVARESE JJ
Citation: Ca. Lien et al., PHARMACOKINETICS OF CISATRACURIUM IN PATIENTS RECEIVING NITROUS-OXIDEOPIOID BARBITURATE ANESTHESIA, Anesthesiology, 84(2), 1996, pp. 300-308
Citation: Ld. Carlton et al., INTRAVENOUS EPOPROSTENOL SODIUM DOES NOT INCREASE HEPATIC-MICROSOMAL ENZYME-ACTIVITY IN RATS, Prostaglandins, 50(5-6), 1995, pp. 341-347
Citation: L. Phillips et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS (PWPD) OF 51W89 IN HEALTHY PEDIATRIC-PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 213-213
Authors:
SCHMITH VD
FIEDLERKELLY J
PHILLIPS L
GRASELA TH
Citation: Vd. Schmith et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS (PW PD) OF 51W89, A NEW NEUROMUSCULAR BLOCKING-AGENT/, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 213-213
Citation: Vd. Schmith et al., EFFECT OF ADVANCED AGE ON THE PHARMACODYNAMICS OF DOXACURIUM - REPLY, Clinical pharmacology and therapeutics, 55(3), 1994, pp. 360-362
Authors:
LIEN CA
SCHMITH VD
EMBREE PB
BELMONT MR
WARGIN WA
SAVARESE JJ
Citation: Ca. Lien et al., THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE STEREOISOMERS OF MIVACURIUM IN PATIENTS RECEIVING NITROUS OXIDE OPIOID/BARBITURATE ANESTHESIA/, Anesthesiology, 80(6), 1994, pp. 1296-1302